Biotricity Inc
OTC:BTCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Biotricity Inc
Accounts Receivables
Biotricity Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biotricity Inc
OTC:BTCY
|
Accounts Receivables
$1.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
25%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Accounts Receivables
$119.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Accounts Receivables
$135.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Accounts Receivables
$216.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Accounts Receivables
$177m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotricity Inc
Glance View
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
See Also
What is Biotricity Inc's Accounts Receivables?
Accounts Receivables
1.6m
USD
Based on the financial report for Dec 31, 2025, Biotricity Inc's Accounts Receivables amounts to 1.6m USD.
What is Biotricity Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
2%
Over the last year, the Accounts Receivables growth was 28%. The average annual Accounts Receivables growth rates for Biotricity Inc have been -7% over the past three years , 2% over the past five years .
